Related Experiment Videos
Interval results with right gastroepiploic bypass.
Thomas Z Lajos1, Mohammed Akhter, Jacob Bergsland
1State University of New York at Buffalo General Hospital, School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
The Heart Surgery Forum
|January 15, 2004
Summary
Minimally invasive right gastroepiploic artery bypass grafting in high-risk patients demonstrated excellent long-term graft patency and low mortality. This off-pump technique offers a viable surgical option for complex coronary artery disease requiring reoperation.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Cardiac Surgery
- Coronary Artery Bypass Grafting
Background:
- Right gastroepiploic artery bypass grafting is a recognized surgical option since the mid-1980s.
- Long-term graft patency remains a critical consideration for this procedure.
- Minimally invasive techniques have emerged to address surgical challenges.
Purpose of the Study:
- To evaluate the efficacy of off-pump, minimally invasive right gastroepiploic artery bypass grafting.
- To assess long-term graft patency and patient outcomes in a high-risk cohort.
- To analyze results in patients with reoperative coronary artery disease.
Main Methods:
- A series of 43 patients (44-79 years) underwent off-pump, minimally invasive right gastroepiploic artery bypass grafting via a subxiphoid incision.
- All patients had Canadian Cardiovascular Society class III-IV heart disease, with 81.3% having undergone 1-3 reoperations.
- Follow-up averaged 57.9 months, including Doppler studies and angiography for patency assessment.
Main Results:
- Forty-one of 43 patients (95.3%) survived at a mean follow-up of 57.4 months.
- Graft patency rates were high, with Doppler studies showing 95.3% and angiography confirming 91.6% patency.
- Postoperative complications were minimal (7%), with a crude mortality of 2.3%.
Conclusions:
- Minimally invasive, off-pump right gastroepiploic artery bypass grafting is a safe and effective option for high-risk patients with reoperative coronary artery disease.
- The procedure yields favorable long-term graft patency and low mortality rates.
- This approach provides a viable surgical choice with excellent outcomes in a challenging patient population.